Search Results - "Lin, Xuede"

Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboring c-Kit Mutation or Amplification by Guo, Jun, Si, Lu, Kong, Yan, Flaherty, Keith T, Xu, Xiaowei, Zhu, Yanyan, Corless, Christopher L, Li, Li, Li, Haifu, Sheng, Xinan, Cui, Chuanliang, Chi, Zhihong, Li, Siming, Han, Mei, Mao, Lili, Lin, Xuede, Du, Nan, Zhang, Xiaoshi, Li, Junling, Wang, Baocheng, Qin, Shukui

“…Melanomas harbor aberrations in the c-Kit gene. We tested the efficiency of the tyrosine kinase inhibitor imatinib in selected patients with metastatic…”
Get full text

Histological characterisation and prognostic evaluation of 62 gastric neuroendocrine carcinomas by Deng, Yujie, Chen, Xiaohui, Ye, Yuhong, Shi, Xi, Zhu, Kunshou, Huang, Liming, Zhang, Sheng, Ying, Mingang, Lin, Xuede

“…To determine the significance of expression of synaptophysin, chromogranin A, and Ki-67 and their association with clinicopathological parameters, and to find…”
Get full text

CCL21 induces extensive intratumoral immune cell infiltration and specific anti-tumor cellular immunity by TURNQUIST, Heth R, XUEDE LIN, ASHOURI, Abdelkader E, HOLLINGSWORTH, Michael A, SINGH, Rakesh K, TALMADGE, James E, SOLHEIM, Joyce C

“…Chemokines are vital messengers that regulate immune cell activity. The chemokine CCL21 is normally expressed in secondary lymphoid organs and acts as a…”
Get full text

Effect of invariant chain on major histocompatibility complex class I molecule expression and stability on human breast tumor cell lines by Lin, Xuede, Wang, Xiaojian, Capek, Haley L, Simone, Laura C, Tuli, Amit, Morris, Chantey R, Reber, Adrian J, Solheim, Joyce C

“…Invariant chain (Ii) binds to the human leukocyte antigen (HLA) class II molecule and assists it in the process of peptide acquisition. In addition, Ii binds…”
Get full text

CCL21 Is an effective surgical neoadjuvant for treatment of mammary tumors by Ashour, Abdelkader E., Lin, Xuede, Wang, Xiaojian, Turnquist, Heth R., Burns, Nicole M., Tuli, Amit, Sadanandam, Anguraj, Suleiman, Khaled, Singh, Rakesh K., Talmadge, James E., Solheim, Joyce C.

“…In previous studies, the chemokine CCL21 has shown biological activities that include T cell, natural killer (NK) cell, and dendritic cell (DC)…”
Get full text

Reduction in hMSH2 mRNA levels by premature translation termination : Implications for mutation screening in hereditary nonpolyposis colorectal cancer by XUEDE LIN, CHOI, J. H, LYNCH, P, LIXUAN XI, WU, E, FRAZIER, M. L

“…We have used single-strand conformational polymorphism (SSCP) and heteroduplex analysis to examine DNA from 50 colorectal carcinoma patients coming from…”
Get full text

Salvage therapy with mitoxantrone, etoposide, bleomycin and dexamethasone for refractory or relapsed aggressive non-Hodgkin's lymphoma patients with a poor performance status or comorbidity by LIN, XUEDE, SHI, XI, ZENG, WUCHA, ZHENG, MIN, HUANG, LIMING

“…The treatment of refractory or relapsed aggressive non-Hodgkin's lymphoma (NHL) in patients in a state of poor health is difficult due to their ineligibility…”
Get full text

Immune recognition of breast tumor cells by Lin, Xuede

“…The recognition and destruction of cancerous cells by the immune system is a complex process that requires cellular communication via cytokines as well as…”
Get full text

CCL21 is an effective surgical neoadjuvant for treatment of mammary tumors by Ashour, Abdelkader E, Lin, Xuede, Wang, Xiaojian, Turnquist, Heth R, Burns, Nicole M, Tuli, Amit, Sadanandam, Anguraj, Suleiman, Khaled, Singh, Rakesh K, Talmadge, James E, Solheim, Joyce C

“…In previous studies, the chemokine CCL21 has shown biological activities that include T cell, natural killer (NK) cell, and dendritic cell (DC)…”
Get full text

Immune recognition of breast tumor cells by Lin, Xuede

“…The recognition and destruction of cancerous cells by the immune system is a complex process that requires cellular communication via cytokines as well as…”
Get full text

Flt3 ligand delivered in a pluronic formulation prolongs the survival of mice with orthotopic pancreatic adenocarcinoma by Ashour, Abdelkader E, Turnquist, Hēth R, Burns, Nicole, Wang, Xiaojian, Lin, Xuede, Tremayne, Jarrod, Hollingsworth, Michael A, Blonder, Joan M, Rosenthal, Gary J, Talmadge, James E, Solheim, Joyce C

“…Pancreatic adenocarcinoma is a devastating disease, characterized by asymptomatic development and extremely poor prognosis. Given the resistance of pancreatic…”
Get more information